The Guerriero Lab aims to design clinically effective strategies to promote T-cell activation and weaken the immune-suppressive tumor microenvironment to improve immunotherapy response rates in breast cancer patients. We seek to identify tumor-promoting tumor macrophages in breast tumors before and after therapy, elucidate their molecular and metabolic regulation that promotes immune suppression and therapy-resistance and determine how tumor macrophage phenotype, metabolism and function can be modulated for anti-tumor responses.
The lab had a great time at the Northeastern hockey game with friends and family. A great win by the Huskies! #GoHuskies
On November 21st the Guerriero lab attended the 2022 Ludwig Retreat. It was amazing to connect with everyone and discuss all the great work being done at the Ludwig Center…
The lab had a great time at SITC 2022 here in Boston. After great talks at the conference, a chance to discuss with some great food.